It’s a Medscape wrap for EHA2022
June 21, 2022 | CME, CPD, Medscape Oncology, haematology, medical education
EHA2022 Hybrid Congress has now come to a close with the Thematic Days finishing last week. The Medscape team were delighted to connect with so many physicians, colleagues and supporters during the congress.
Medscape Oncology Global held two symposia, attended by over 500 physicians during the congress itself and a minimum additional 2000 Medscape members are expected to participate in the post-congress enduring programs hosted on Medscape.org. Stephen Dunn, Medscape Oncology Global Executive Director commented, “EHA is the largest European-based organization connecting haematologists worldwide to support research and the delivery of vital education – helping to advance clinical practice and improve patient outcomes. Outside of the US, Medscape Oncology Global education reaches over 116,00 haematologists and oncologists with access to a further 100,000+ in China and Japan through our Medscape Education Network, so it was great that our team had a chance to finally meet and chat with thought-leaders and members in person. These conversations play an important part in helping us to better understand their educational needs and clinical gaps which then help us to shape our programmes. We’re now getting ready for EAU, ESMO GI and ESMO in the coming weeks, so we hope to see some familiar faces again; learning never stands still.”
Ahead of the conference, Medscape Education Chief Medical Officer, Hansa Bhargava, MD, previewed the event with a 4-part interview series with key faculty highlighting the latest clinical data being presented and discussing what they mean for managing patients with different haematological malignancies today and in the future. If you missed these, you can now view them via the links below:
- Part 1 of the Medscape video interview series:Hansa Bhargava MD, Medscape Education Chief Medical Officer, interviews Dr Loretta Nastoupil on the most important abstracts to look out for at EHA in lymphoma.
- Part 2 of the Medscape video interview series: Hansa Bhargava MD, Medscape Education Chief Medical Officer interviews Dr John Gribben on the most important abstracts to look out for in CLL.
- Part 3 of the Medscape video series: Hansa Bhargava MD, Medscape Education Chief Medical Officer, interviews Dr Naval Daver on the most important abstracts to look out for in Myeloid.
- Part 4 of the Medscape video interview series: Dr Hansa Bhargava MD interviews Dr Maria Victoria Mateos on the most important abstracts to look out for in multiple myeloma.
Our CME / CPD programmes are designed by experts and powered by the Medscape Professional Network, the world’s number one network of websites for physicians worldwide for the fourth consecutive year*.
Medscape Oncology is committed to improving cancer care through education, if that’s your mission too, contact Stephen Dunn via LinkedIn or by email: sdunn@webmd.net
For everything else, you can contact us through our PMHub here.
About Medscape:
Medscape delivers dynamic, innovative education to optimize learner engagement and patient outcomes worldwide. Medscape is the leading online global destination for physicians and healthcare professionals, providing over 5 million members with the latest medical news, expert opinion, and precision education (CME and CPD) to improve clinical practice and advance health outcomes. Medscape’s unrivalled membership reach and therapeutic expertise deliver education across 30+ specialties in 40+ learning formats, using the latest digital and live technology.
*Clarivate, Taking the Pulse® Europe 2021
This content was provided by Medscape Education
Company Details
Latest Content from Medscape Education
#ShortenTheJourney
For the millions of people living with a rare disease, the path to a diagnosis (if ever received) is often a long and frustrating odyssey. This delay is frequently driven...
Why We Must Stop Normalizing the “Pregnancy Itch”
In the world of rare diseases, success is often measured by the speed of diagnosis. However, for women facing rare liver conditions like Intrahepatic Cholestasis of Pregnancy (ICP), the medical...
The Greatest Form of Caring: Medscape’s Commitment to Advancing Cardiovascular Health
A February Focus on the Heart While February is known as the month of love, it is also National Heart Month, a time for highlighting the importance of cardiovascular health....
AI, Agility, and Connected Impact at Alliance 2026
Join the Medscape team in Atlanta, February 16–19, 2026, as Alliance celebrates 50 years of excellence in continuing education for health professionals. We’re bringing our 3 decades of experience in...
Why Sleep Health is the Missing Link in Women’s Wellness
While obstructive sleep apnea (OSA) affects approximately 32% of US adults—nearly 80 million people—it remains an "epidemic hiding in plain sight". Perhaps most staggering is that 90% of women with...
The Heart and Mouth Connection Every Woman Needs to Know
For decades, modern medicine has treated the mouth and the body as separate entities. But for Dr. Nieca Goldberg, a renowned cardiologist, and Dr. Maria Ryan, Chief Clinical Officer at...
Uncovering Inequities in Alzheimer’s Disease Screening and Care
On December 5, MAPS hosted an educational webinar exploring recent research in Alzheimer’s disease (AD) screening, testing, and treatment. Experts from Komodo Health and Medscape shared findings from their...
Where Are We Today With Artificial Intelligence (AI) in Rare Disease Diagnosis and Care?
Discover how AI-powered tools are transforming rare disease diagnosis, patient care, and clinical decision-making.
Does Rare Disease Education Work?
For a child with a rare disease, a doctor’s continuing education can end a years-long diagnostic odyssey and unlock access to vital care.
From Genetic Puzzles to Precision Therapeutics
How was a new rare disease discovered through Singapore’s Undiagnosed Disease Program? And how will technology allow us to change how we discover rare diseases in the future? Read more...